Book Cover
Home  |   Healthcare   |  Cell Therapy Market

Cell Therapy Market Size, Share, Growth, and Industry Analysis, By Type (Stem Cell Therapies, Non-Stem Cell Therapies), By Application (Hospital, Clinic), Regional Insights and Forecast to 2035

Trust Icon
1000+
GLOBAL LEADERS TRUST US
Table of Content

1 Market Overview
1.1 Product Definition and Market Characteristics
1.2 Global Cell Therapy Market Size
1.3 Market Segmentation
1.4 Regulatory Environment

2 Industry Chain Analysis
2.1 Industry Chain Analysis
2.2 Cell Therapy Raw Materials Analysis
2.2.1 Key Raw Materials Introduction
2.2.2 Key Suppliers of Raw Materials
2.3 Cell Therapy Business Mode and Production Process
2.3.1 Cell Therapy Business Mode Analysis
2.3.2 Production Process Analysis
2.4 Cell Therapy Cost Structure Analysis
2.4.1 Manufacturing Cost Structure of Cell Therapy
2.4.2 Raw Material Cost of Cell Therapy
2.4.3 Labor Cost of Cell Therapy
2.5 Market Channel Analysis
2.6 Major Downstream Customers Analysis
2.7 Alternative Product Analysis

3 Market Dynamics
3.1 Market Drivers
3.2 Market Constraints and Challenges
3.3 Emerging Market Trends
3.4 PESTEL Analysis
3.5 Consumer Insights Analysis
3.6 Impact of Russia and Ukraine War

4 Market Competitive Landscape
4.1 Global Cell Therapy Revenue and Market Share by Manufacturer (2021-2026)
4.2 Global Cell Therapy Sales Volume and Market Share by Manufacturer (2021-2026)
4.3 Global Cell Therapy Price by Manufacturer (2021-2026)
4.4 Cell Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
4.5 Global Key Manufacturers of Cell Therapy, Manufacturing Base Distribution and Headquarters
4.6 Global Key Manufacturers of Cell Therapy, Product Offered and Application
4.7 Cell Therapy Market Competitive Situation and Trends
4.7.1 Cell Therapy Market Concentration Rate
4.7.2 Global Top 3 and Top 6 Cell Therapy Players Market Share by Revenue
4.8 Industry News
4.8.1 Key Product Launch News
4.8.2 Mergers & Acquisitions, Expansion Plans

5 Global Cell Therapy Market Historical Development by Geographic Region (2021-2026)
5.1 Global Cell Therapy Market Historical Sales Volume by Geographic Region (2021-2026)
5.2 Global Cell Therapy Market Historical Revenue by Geographic Region (2021-2026)
5.3 North America Cell Therapy Market Status by Country (2021-2026)
5.3.1 North America Cell Therapy Sales Volume by Country (2021-2026)
5.3.2 North America Cell Therapy Revenue by Country (2021-2026)
5.3.3 United States Cell Therapy Sales Volume, Revenue and Growth (2021-2026)
5.3.4 Canada Cell Therapy Sales Volume, Revenue and Growth (2021-2026)
5.4 Europe Cell Therapy Market Status by Country (2021-2026)
5.4.1 Europe Cell Therapy Sales Volume by Country (2021-2026)
5.4.2 Europe Cell Therapy Revenue by Country (2021-2026)
5.4.3 Germany Cell Therapy Sales Volume, Revenue and Growth (2021-2026)
5.4.4 France Cell Therapy Sales Volume, Revenue and Growth (2021-2026)
5.4.5 United Kingdom Cell Therapy Sales Volume, Revenue and Growth (2021-2026)
5.4.6 Spain Cell Therapy Sales Volume, Revenue and Growth (2021-2026)
5.4.7 Russia Cell Therapy Sales Volume, Revenue and Growth (2021-2026)
5.4.8 Poland Cell Therapy Sales Volume, Revenue and Growth (2021-2026)
5.5 Asia Pacific Cell Therapy Market Status by Country (2021-2026)
5.5.1 Asia Pacific Cell Therapy Sales Volume by Country (2021-2026)
5.5.2 Asia Pacific Cell Therapy Revenue by Country (2021-2026)
5.5.3 China Cell Therapy Sales Volume, Revenue and Growth (2021-2026)
5.5.4 Japan Cell Therapy Sales Volume, Revenue and Growth (2021-2026)
5.5.5 South Korea Cell Therapy Sales Volume, Revenue and Growth (2021-2026)
5.5.6 Southeast Asia Cell Therapy Sales Volume, Revenue and Growth (2021-2026)
5.5.7 India Cell Therapy Sales Volume, Revenue and Growth (2021-2026)
5.5.8 Australia Cell Therapy Sales Volume, Revenue and Growth (2021-2026)
5.6 Latin America Cell Therapy Market Status by Country (2021-2026)
5.6.1 Latin America Cell Therapy Sales Volume by Country (2021-2026)
5.6.2 Latin America Cell Therapy Revenue by Country (2021-2026)
5.6.3 Mexico Cell Therapy Sales Volume, Revenue and Growth (2021-2026)
5.6.4 Brazil Cell Therapy Sales Volume, Revenue and Growth (2021-2026)
5.7 Middle East and Africa Cell Therapy Market Status by Country (2021-2026)
5.7.1 Middle East and Africa Cell Therapy Sales Volume by Country (2021-2026)
5.7.2 Middle East and Africa Cell Therapy Revenue by Country (2021-2026)
5.7.3 GCC Cell Therapy Sales Volume, Revenue and Growth (2021-2026)
5.7.4 South Africa Cell Therapy Sales Volume, Revenue and Growth (2021-2026)

6 Global Cell Therapy Market Historical Development by Product Type (2021-2026)
6.1 Cell Therapy Definition by Type
6.2 Global Cell Therapy Historical Sales Volume by Product Type (2021-2026)
6.3 Global Cell Therapy Historical Revenue by Product Type (2021-2026)
6.4 Global Cell Therapy Historical Price by Product Type (2021-2026)
6.5 Global Historical Sales Volume, Revenue and Growth Rate by Product Type (2021-2026)
6.5.1 Global Cell Therapy Historical Sales Volume, Revenue and Growth Rate of Stem Cell Therapies (2021-2026)
6.5.2 Global Cell Therapy Historical Sales Volume, Revenue and Growth Rate of Non-Stem Cell Therapies (2021-2026)

7 Global Cell Therapy Market Historical Development by End User (2021-2026)
7.1 Downstream Market Overview
7.2 Global Cell Therapy Historical Sales Volume by End User (2021-2026)
7.3 Global Cell Therapy Historical Revenue by End User (2021-2026)
7.4 Global Cell Therapy Historical Price by End User (2021-2026)
7.5 Global Historical Sales Volume, Revenue and Growth Rate by End User (2021-2026)
7.5.1 Global Cell Therapy Historical Sales Volume, Revenue and Growth Rate of Hospital (2021-2026)
7.5.2 Global Cell Therapy Historical Sales Volume, Revenue and Growth Rate of Clinic (2021-2026)

8 Leading Companies Profiles
8.1 MEDIPOST
8.1.1 MEDIPOST Corporation Information
8.1.2 MEDIPOST - Cell Therapy Product Portfolio and Specification
8.1.3 MEDIPOST Performance Analysis (2021-2026)
8.1.4 MEDIPOST Business and Markets Served
8.1.5 MEDIPOST Recent Developments
8.2 Atara Biotherapeutics
8.2.1 Atara Biotherapeutics Corporation Information
8.2.2 Atara Biotherapeutics - Cell Therapy Product Portfolio and Specification
8.2.3 Atara Biotherapeutics Performance Analysis (2021-2026)
8.2.4 Atara Biotherapeutics Business and Markets Served
8.2.5 Atara Biotherapeutics Recent Developments
8.3 Novartis AG
8.3.1 Novartis AG Corporation Information
8.3.2 Novartis AG - Cell Therapy Product Portfolio and Specification
8.3.3 Novartis AG Performance Analysis (2021-2026)
8.3.4 Novartis AG Business and Markets Served
8.3.5 Novartis AG Recent Developments
8.4 JW Therapeutics
8.4.1 JW Therapeutics Corporation Information
8.4.2 JW Therapeutics - Cell Therapy Product Portfolio and Specification
8.4.3 JW Therapeutics Performance Analysis (2021-2026)
8.4.4 JW Therapeutics Business and Markets Served
8.4.5 JW Therapeutics Recent Developments
8.5 JCR Pharmaceuticals Co., Ltd.
8.5.1 JCR Pharmaceuticals Co., Ltd. Corporation Information
8.5.2 JCR Pharmaceuticals Co., Ltd. - Cell Therapy Product Portfolio and Specification
8.5.3 JCR Pharmaceuticals Co., Ltd. Performance Analysis (2021-2026)
8.5.4 JCR Pharmaceuticals Co., Ltd. Business and Markets Served
8.5.5 JCR Pharmaceuticals Co., Ltd. Recent Developments
8.6 Aurion Biotech
8.6.1 Aurion Biotech Corporation Information
8.6.2 Aurion Biotech - Cell Therapy Product Portfolio and Specification
8.6.3 Aurion Biotech Performance Analysis (2021-2026)
8.6.4 Aurion Biotech Business and Markets Served
8.6.5 Aurion Biotech Recent Developments
8.7 Anterogen Co., Ltd.
8.7.1 Anterogen Co., Ltd. Corporation Information
8.7.2 Anterogen Co., Ltd. - Cell Therapy Product Portfolio and Specification
8.7.3 Anterogen Co., Ltd. Performance Analysis (2021-2026)
8.7.4 Anterogen Co., Ltd. Business and Markets Served
8.7.5 Anterogen Co., Ltd. Recent Developments
8.8 Johnson & Johnson Services, Inc
8.8.1 Johnson & Johnson Services, Inc Corporation Information
8.8.2 Johnson & Johnson Services, Inc - Cell Therapy Product Portfolio and Specification
8.8.3 Johnson & Johnson Services, Inc Performance Analysis (2021-2026)
8.8.4 Johnson & Johnson Services, Inc Business and Markets Served
8.8.5 Johnson & Johnson Services, Inc Recent Developments
8.9 S. BIOMEDICS
8.9.1 S. BIOMEDICS Corporation Information
8.9.2 S. BIOMEDICS - Cell Therapy Product Portfolio and Specification
8.9.3 S. BIOMEDICS Performance Analysis (2021-2026)
8.9.4 S. BIOMEDICS Business and Markets Served
8.9.5 S. BIOMEDICS Recent Developments
8.10 Gilead Sciences, Inc.
8.10.1 Gilead Sciences, Inc. Corporation Information
8.10.2 Gilead Sciences, Inc. - Cell Therapy Product Portfolio and Specification
8.10.3 Gilead Sciences, Inc. Performance Analysis (2021-2026)
8.10.4 Gilead Sciences, Inc. Business and Markets Served
8.10.5 Gilead Sciences, Inc. Recent Developments
8.11 Holostem Terapie Avanzate S.r.l
8.11.1 Holostem Terapie Avanzate S.r.l Corporation Information
8.11.2 Holostem Terapie Avanzate S.r.l - Cell Therapy Product Portfolio and Specification
8.11.3 Holostem Terapie Avanzate S.r.l Performance Analysis (2021-2026)
8.11.4 Holostem Terapie Avanzate S.r.l Business and Markets Served
8.11.5 Holostem Terapie Avanzate S.r.l Recent Developments
8.12 Nkarta, Inc.
8.12.1 Nkarta, Inc. Corporation Information
8.12.2 Nkarta, Inc. - Cell Therapy Product Portfolio and Specification
8.12.3 Nkarta, Inc. Performance Analysis (2021-2026)
8.12.4 Nkarta, Inc. Business and Markets Served
8.12.5 Nkarta, Inc. Recent Developments
8.13 Bristol-Myers Squibb Company
8.13.1 Bristol-Myers Squibb Company Corporation Information
8.13.2 Bristol-Myers Squibb Company - Cell Therapy Product Portfolio and Specification
8.13.3 Bristol-Myers Squibb Company Performance Analysis (2021-2026)
8.13.4 Bristol-Myers Squibb Company Business and Markets Served
8.13.5 Bristol-Myers Squibb Company Recent Developments

9 Global Cell Therapy Market Forecast by Product Type and End User (2026-2034)
9.1 Global Cell Therapy Market Forecast by Product Type (2026-2034)
9.1.1 Global Cell Therapy Sales Volume, Revenue Forecast and Growth Rate of Stem Cell Therapies (2026-2034)
9.1.2 Global Cell Therapy Sales Volume, Revenue Forecast and Growth Rate of Non-Stem Cell Therapies (2026-2034)
9.2 Global Cell Therapy Market Forecast by End User (2026-2034)
9.2.1 Global Cell Therapy Sales Volume, Revenue Forecast and Growth Rate of Hospital (2026-2034)
9.2.2 Global Cell Therapy Sales Volume, Revenue Forecast and Growth Rate of Clinic (2026-2034)

10 Global Cell Therapy Market Forecast by Geographic Region (2026-2034)
10.1 Global Cell Therapy Sales Volume and Revenue Forecast by Geographic Region (2026-2034)
10.2 North America Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)
10.2.1 United States Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)
10.2.2 Canada Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3 Europe Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.1 Germany Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.2 France Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.3 United Kingdom Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.4 Spain Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.5 Russia Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)
10.3.6 Poland Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4 Asia Pacific Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.1 China Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.2 Japan Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.3 South Korea Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.4 Southeast Asia Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.5 India Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)
10.4.6 Australia Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)
10.5 Latin America Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)
10.5.1 Mexico Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)
10.5.2 Brazil Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)
10.6 Middle East and Africa Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)
10.6.1 GCC Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)
10.6.2 South Africa Cell Therapy Sales Volume, Revenue Forecast and Growth (2026-2034)

11 Appendix
11.1 Methodology
11.2 Research Data Source
11.2.1 Secondary Data
11.2.2 Primary Data
11.2.3 Market Size Estimation
11.2.4 Legal Disclaimer
 
Captcha refresh

Trusted & Certified

Our Clients